levonorgestrel has been researched along with Hyperplasia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Buca, D; D'Antonio, F; De Rocco, S; Dessole, M; Fanfani, F; Leombroni, M; Liberati, M; Lucidi, A; Nappi, L; Oronzii, L; Petrillo, M; Scambia, G | 1 |
| Jiang, J; Li, X; Peng, H | 1 |
| Chin, JPS; Mok, ZW | 1 |
| Chen, X | 1 |
| Manyonda, I; Talaulikar, VS | 1 |
| Bottles, K; Darney, PD; Klaisle, C; Taylor, RN; Zaloudek, C | 1 |
| Bennink, HC; Mascarenhas, L; Newton, J; van Beek, A | 1 |
| Varma, TR | 1 |
3 review(s) available for levonorgestrel and Hyperplasia
| Article | Year |
|---|---|
Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Precancerous Conditions; Pregnancy; Pregnancy Outcome | 2022 |
Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Progestins; Tumor Suppressor Protein p53 | 2022 |
Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
Topics: Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Hyperplasia; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone | 2012 |
1 trial(s) available for levonorgestrel and Hyperplasia
| Article | Year |
|---|---|
A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
Topics: Adolescent; Adult; Cervix Uteri; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Levonorgestrel; Prospective Studies; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears; Vinyl Compounds | 1998 |
5 other study(ies) available for levonorgestrel and Hyperplasia
| Article | Year |
|---|---|
Rare case of coexisting ovarian Brenner tumour and ovarian stromal hyperplasia presenting with persistent endometrial hyperplasia following treatment with levonorgestrel-intrauterine system.
Topics: Brenner Tumor; Endometrial Hyperplasia; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms | 2022 |
The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia.
Topics: Conservative Treatment; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Humans; Hyperplasia; Levonorgestrel; Retrospective Studies | 2019 |
ACOG committee opinion. No. 337: Noncontraceptive uses of the levonorgestrel intrauterine system.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Intrauterine Devices; Levonorgestrel; Menorrhagia; Selective Estrogen Receptor Modulators; Tamoxifen | 2006 |
Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users.
Topics: Adult; Contraceptive Agents, Female; Drug Implants; Endometrium; Estradiol; Female; Humans; Hyperplasia; Levonorgestrel; Progesterone; Time Factors; Uterine Hemorrhage | 1996 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |